Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Mainz Biomed N.V. - Ordinary Shares (NQ: MYNZ ) 0.4244 -0.0034 (-0.79%) Streaming Delayed Price Updated: 3:59 PM EDT, Jul 17, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Mainz Biomed N.V. - Ordinary Shares < Previous 1 2 3 4 5 6 7 8 9 Next > Mainz Biomed Processes First Patients from Colorectal Cancer Screening Campaign Through its Corporate Health Portal in Partnership with Zöeller-Kipper May 24, 2023 From Mainz BioMed NV Via GlobeNewswire Mainz Biomed Announces First Quarter 2023 Financial Results and Provides Corporate Update May 16, 2023 From Mainz BioMed NV Via GlobeNewswire A New Groundbreaking Tool to Detect Colon Cancer Earlier May 10, 2023 A novel blood test for detecting colon cancer, the third most lethal type of cancer in the US, has been created. The Colorectal Cancer Screening Blood Test can identify cancer at early stages. This... Via PressReach Exposures Product Safety Expert Ratings for Mainz Biomed April 27, 2023 Via Benzinga Colon Cancer Creeping Into Younger Adults – New R&D Uncovers Early Signs May 10, 2023 Spots of blood after bowel movements, stomach aches, and protracted episodes of diarrhea may be symptoms of early-onset colorectal cancer, which is increasingly diagnosed in young adults who are... Via PressReach Mainz Biomed Partners with Microba Life Sciences for the Development of PancAlert May 10, 2023 From Mainz BioMed NV Via GlobeNewswire AI Tool Predicts Colon Cancer Survivorship and Response to Treatment May 03, 2023 Harvard Medical School and National Cheng Kung University in Taiwan have designed an artificial intelligence (AI) algorithm to improve colorectal cancer prognosis and treatment options. The new... Via PressReach Topics Artificial Intelligence Exposures Artificial Intelligence New Artificial Intelligence Tool Can Diagnose Colon Cancer May 03, 2023 A new artificial intelligence (AI) model developed by Harvard Medical School and Taiwan’s National Cheng Kung University could provide much-needed clarity to clinicians presenting prognoses and... Via PressReach Topics Artificial Intelligence Death Exposures Artificial Intelligence Death Product Safety Mainz Biomed Announces Addition of Eurofins GeLaMed to its Growing Network of Lab Partners May 03, 2023 From Mainz BioMed NV Via GlobeNewswire Mainz Biomed to Participate in Digestive Disease Week 2023 May 01, 2023 Largest international meeting of physicians, researchers, and academics covering gastroenterology, hepatology, endoscopy, and gastrointestinal surgery From Mainz BioMed NV Via GlobeNewswire Why NETGEAR Shares Are Trading Lower By 18%? Here Are Other Stocks Moving In Thursday's Mid-Day Session April 27, 2023 Gainers Evelo Biosciences, Inc. (NASDAQ: EVLO) jumped 147.9% to $0.2479. Evelo Biosciences shares dropped 33% on Wednesday after the company announced top-line data from the fourth cohort of its... Via Benzinga Mainz Biomed to Commence Quarterly Reporting and Present at Equity Forum Spring Conference 2023 in Frankfurt, Germany April 27, 2023 From Mainz BioMed NV Via GlobeNewswire Mainz Biomed Announces Partnership with the Instituto de Microecologia to Expand ColoAlert® Commercialization in Spain and Portugal April 26, 2023 The Instituto de Microecologia to market at-home detection test for colorectal cancer to physicians and their patients From Mainz BioMed NV Via GlobeNewswire Stocks That Hit 52-Week Lows On Wednesday April 19, 2023 During Wednesday's trading, 123 companies set new 52-week lows. Via Benzinga Stocks That Hit 52-Week Lows On Tuesday April 25, 2023 Tuesday's session saw 286 companies set new 52-week lows. Via Benzinga Stocks That Hit 52-Week Lows On Friday April 21, 2023 During Friday's session, 149 stocks hit new 52-week lows. Via Benzinga Mainz Biomed Provides Full Year 2022 Financial Results April 10, 2023 From Mainz BioMed NV Via GlobeNewswire Stocks That Hit 52-Week Lows On Thursday April 20, 2023 During Thursday's session, 99 companies made new 52-week lows. Via Benzinga Mainz Biomed Expands Corporate Health Program for ColoAlert with the Addition of Three New Companies in Germany April 04, 2023 From Mainz BioMed NV Via GlobeNewswire Mainz Biomed Reports Positive Results from Feasibility Study Evaluating its Portfolio of Novel mRNA Biomarkers for Early Detection of Advanced Colorectal Adenomas March 29, 2023 From Mainz BioMed NV Via GlobeNewswire Analysts Model Over 74% Upside For Mainz Biomed Stock Ahead Of Key 1/H 2023 Updates ($MYNZ) March 23, 2023 Via AB Newswire Mainz Biomed ($MYNZ) Inks Accretive Partnership To Expand Marketing Reach Of ColoAlert Diagnostic, Analysts Model For Over 72% Upside ($MYNZ) March 21, 2023 Via AB Newswire Mainz Biomed to Present at Sidoti Virtual Investor Conference March 22-23 March 21, 2023 From Mainz BioMed NV Via GlobeNewswire Mainz Biomed Announces Partnership with Labor Staber to Expand ColoAlert Commercialization in Germany March 15, 2023 Labor Staber to actively market and sell ColoAlert to its physician and patient network. From Mainz BioMed NV Via GlobeNewswire In Focus: Mainz Biomed Nears Multiple Data Set Releases Expected To Fuel 2023 Growth ($MYNZ) March 14, 2023 Via AB Newswire Mainz Biomed Launches Number of Educational Events in Germany to Raise Awareness for CRC Screening and Early Detection March 08, 2023 From Mainz BioMed NV Via GlobeNewswire Mainz Biomed In Focus Ahead Of Two Data-Set Releases In 1H/2023 ($MYNZ) March 07, 2023 Via AB Newswire Mainz Biomed Recognizes Colorectal Cancer Awareness Month Throughout “Blue” March 2023 March 01, 2023 Mainz Biomed to host several events for patients and healthcare professionals in Germany to increase awareness about the importance of early detection of colorectal cancer. From Mainz BioMed NV Via GlobeNewswire Mainz Biomed to Appear on ClearThink IR’s Virtual Live Event on Wednesday, March 1, 2023 at 12 Noon ET February 28, 2023 Virtual Fireside Chat via Paltalk Platform From Mainz BioMed NV Via GlobeNewswire Mainz Biomed’s Milestones Reached In 2022 Can Be Catalysts In 1/H 2023…Here’s Why ($MYNZ) February 28, 2023 Via AB Newswire < Previous 1 2 3 4 5 6 7 8 9 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.